Strategic Intelligence for Healthcare and Life Sciences
Harness the intelligence of an AI agent to transform public market signals into board-ready opportunity briefs — autonomously, before a single engineering resource is committed.
See the OpportunityThe Problem
P&L owners in Healthcare and Life Sciences companies recognize untapped product opportunities but lack the data-backed justification and visual evidence needed to build internal consensus and act on them. The sector's bureaucratic nature and regulatory complexity make intuition-based roadmapping the norm — leaving revenue opportunities unaddressed and competitive gaps widening.
The primary input for most Healthcare and Life Sciences product roadmaps today — not market data, not competitive signals.
Internal consensus building stalls even clear opportunities, while competitors move on open market gaps.
P&L owners lack a visually compelling, data-backed artifact to own and champion at the executive level.
Target Customer
Who They Are
Company Profile
Their Frustration
What Success Looks Like
Go-To-Market Motion
A value-first motion where the analysis is the pitch. The P&L owner becomes the internal champion before any commercial conversation begins.
A free public-data analysis of a prospect's existing product portfolio is delivered with no strings attached.
3–5 prioritized, revenue-backed opportunity briefs emerge from the analysis — specific, visual, and immediately useful.
The P&L owner has something to own and present internally. Commercial conversation follows naturally from demonstrated value.
MVP Scope
Opportunity title and market signal summary
Revenue impact estimate
Competitive landscape snapshot
AI-generated visual mockup — automatic, no user input required
Recommended next step
Export as PDF, interactive web view, or PowerPoint
Competitor identification: Piche suggests, user confirms.
Pricing
Free
One analysis, always
Professional
Per year
Enterprise
Contact for pricing
"Anchor to revenue opportunity surfaced, not to product features. Success-based pricing reserved as a marketing narrative, not a billing mechanism. Unit economics validated during early customer analyses before usage costs are finalized."
What's Next
Phase 1 establishes Piche as the go-to brief for public-data opportunity discovery. Phase 2 deepens the intelligence layer with proprietary and private data.